New drug combo offers hope for advanced gallbladder cancer patients
NCT ID NCT07310069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new combination of chemotherapy and two immunotherapy drugs in people with advanced gallbladder cancer that cannot be removed by surgery. The goal is to see if the treatment can shrink tumors enough to allow surgery or improve response. About 44 adults aged 18-75 with good organ function may join.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GALLBLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xinhua hospital
Shanghai, Shanghai Municipality, 200092, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.